ELUTIA INC. - CLASS A
3,6900
06-ноября-24 15:59:50
15 мин. задержка
Акции
-0,1400
-3,66%
Сегодняшний диапазон
3,5150 - 3,8800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
13 ноя 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
09 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
06 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
20 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Elutia Announces Private Placement for Proceeds Up to $26 Million
19 сен 2023 08:36:23 Источник Nasdaq GlobeNewswire
-
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
18 сен 2023 16:08:42 Источник Nasdaq GlobeNewswire
-
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
06 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
30 авг 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
14 авг 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
31 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
13 июл 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
19 май 2023 08:15:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
10 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
03 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
20 апр 2023 16:30:50 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Record Full Year 2022 Revenues
22 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
22 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope
20 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
15 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire